Skip to main content

Michel Vounatsos

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michel Vounatsos

Michel Vounatsos is recorded as CEO at Biogen Inc. (BIIB). The proxy statement of Biogen Inc. reports total compensation of $26,625,221 for Michel Vounatsos in fiscal 2022, including a base salary of $1,626,039. Disclosed compensation is on record for 5 fiscal years. Michel Vounatsos has spoken on 10 earnings calls across 1 company, most recently for Biogen Inc. on October 25, 2022.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Biogen Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2022 Biogen Inc. (BIIB) $1,626,039 $26,625,221
2021 Biogen Inc. (BIIB) $1,533,173 $17,689,665
2020 Biogen Inc. (BIIB) $1,488,462 $18,659,829
2019 Biogen Inc. (BIIB) $1,388,461 $18,159,858
2018 Biogen Inc. (BIIB) $1,276,923 $16,168,646

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.